Access the right experts for every study.
A proprietary network of verified life sciences professionals across the entire drug development lifecycle. Built over years. Maintained through established relationships, not cold outreach.
Discuss Your Project → Join the Panel →What makes this network different.
Most fieldwork agencies rent access. We built ours from the ground up, and we maintain every relationship directly.
Every panellist has been personally recruited and verified. We know their specialisms, their seniority, and their availability. No cold outreach, no purchased lists, no surprises.
Panel members are validated against professional credentials, employment history, and therapeutic area expertise. This means higher data quality and fewer screening failures for your projects.
Coverage across Europe, North America, Asia-Pacific, the Middle East, and Latin America. Strong local-market depth in key regions, not just superficial geographic spread.
Because our relationships are active and maintained, we recruit faster than agencies relying on third-party panels. Most studies are fully recruited within 72 hours.
GDPR-compliant data handling, MRS Code of Conduct, IQCS-audited processes. Panel members provide informed consent and are managed in accordance with industry best practice.
Our dedicated panel development team actively recruits and nurtures the network. As your research needs evolve, our panel evolves with them.
Custom & client-list recruitment.
Sometimes a study needs people the panel doesn't yet cover — an ultra-niche subspeciality, a client's own contact list, a rare-disease community, or a handful of decision-makers inside a specific set of companies. When that happens, we go and find them.
We can work directly from a contact list you supply — customers, prospects, HCPs you already know, internal stakeholders, or named specialists. We handle the outreach, screening, scheduling, consent and incentive management end-to-end, with full GDPR and MRS compliance.
Ultra-specialist clinicians, sub-5% market payers, a specific medical-device buying committee, rare-disease KOLs — if they exist, we'll map the universe, identify the right people, and recruit them directly rather than forcing a study to fit who happens to be available.
For longer programmes we build and maintain dedicated study-specific panels — recruited to your exact criteria, managed through the life of the project, and available for follow-up waves without starting from zero each time.
Professionals across life sciences and the broader science economy.
From discovery bench to commercialisation, and from pharma into applied science — our panel covers the people who design, run, buy for, and work in the labs that keep science moving.
- Discovery & preclinical scientists
- Translational & clinical researchers
- Regulatory affairs specialists
- Medical affairs professionals
- Market access & HEOR specialists
- Commercial & launch strategists
- Payers & formulary decision-makers
- Physicians & healthcare professionals
- Laboratory, analytical & diagnostics professionals
- Food, water, environmental & materials testing scientists
- QA/QC, metrology & instrumentation users
- Procurement & lab supply-chain specialists
Our panel isn't limited to one stage of the value chain, or even to one industry. Whether your study needs a conversation with a Phase I clinical investigator, a regional payer, a commercial director preparing for launch, or a laboratory manager running food-safety assays on a mass spec, we can connect you with the right person.
We also work with the people on the other side of the bench: the scientists and technicians who use laboratory instruments, reagents, consumables and software every day. That includes pharma and biotech labs, but also clinical diagnostics, contract research and testing organisations, food and beverage testing, water and environmental testing, academic and government research facilities, and industrial R&D.
Therapeutic and technical coverage includes oncology, immunology, rare diseases, cardiovascular, neurology, respiratory, infectious disease, analytical chemistry, molecular biology, microbiology, and more. Panel members span all career levels, from hands-on practitioners to C-suite decision-makers.
We actively maintain and expand the panel across key markets, with particular depth in the UK, Germany, France, the US, the Gulf region, India, South Korea, and China.
Research where your markets are.
We maintain active panel coverage across three core regions, with the depth to support both multi-country studies and single-market deep dives.
Deep coverage across the UK, Germany, France, Spain, Italy, Nordics, and Benelux. Strong access to both Western and Central European markets, including payers, regulators, and KOLs across major therapeutic areas.
Established panel presence across the United States and Canada. Coverage spans clinical, regulatory, commercial, and payer audiences — from community physicians to C-suite pharma executives.
Growing coverage across key Asian markets including India, Japan, South Korea, China, and Southeast Asia. Access to local clinical researchers, regulatory specialists, and commercial decision-makers in high-growth markets.
MRS Company Partner
EphMRA Member
IQCS Audited
GDQ Quality Standards
MRBA Supporter
Cyber EssentialsThe foundation of everything we do.
Our panel doesn't just serve one capability. It powers both our market research and science advisory arms, creating a single source of verified expertise.
When Connect runs a study, respondents come from our own panel first. That means established relationships, faster recruitment, and professionals who are genuinely qualified for the research. No third-party panel aggregators needed.
Learn about Connect →When Avrion needs a biomarker specialist or a regulatory strategist for an advisory board, the panel provides direct access to verified experts. Every advisory engagement benefits from real relationships, not cold approaches.
Learn about Avrion →Because our panel, market research, and science advisory share the same infrastructure, every engagement draws on the full depth of our network. Your research is sharper because it's backed by established expert relationships. Your advisory work is grounded because it connects to real market data.